Job Title: Associate Director Real World Evidence (RWE) Science Phase IV / Post-Approval (Contract)
Location: United States (Remote; Eastern Time business hours preferred)
Duration: 7-Month Contract (Full-Time 40 hours/week)
Start: Targeting Early March 2026
We are seeking an experienced Associate Director Real World Evidence (RWE) Science to provide coverage for a Phase IV / post-approval RWE portfolio within a global Medical Affairs environment. This is a senior-level individual contributor role requiring deep epidemiology and real-world evidence expertise strong methodological leadership and the ability to independently manage ongoing studies with minimal ramp-up.
This position supports global stakeholders including Europe and requires flexibility for early morning meetings aligned to EU collaboration.
Key Responsibilities
-
Lead scientific oversight of Phase IV and post-approval real-world evidence (RWE) and observational studies
-
Provide methodological and technical leadership for study design feasibility assessments and evidence planning (EU focus)
-
Oversee vendors/CROs conducting outsourced analyses; review protocols statistical analysis plans and outputs to ensure scientific rigor
-
Conduct and/or supervise systematic literature reviews (SLRs) and meta-analyses
-
Contribute to development of RWE plans aligned with regulatory HTA and post-approval commitments
-
Support retrospective analyses leveraging real-world data sources (claims EHR registries)
-
Guide protocol development for observational studies and pragmatic trials
-
Perform evidence reviews to inform regulatory submissions reimbursement strategy and medical strategy
-
Collaborate with Regional Medical Affairs on scientific exchange and external RWE engagement
-
Support development of abstracts posters manuscripts and internal scientific communications
Required Qualifications
-
Advanced degree (MD PhD or MS) in Epidemiology Biostatistics Public Health or related field
-
8 10 years of progressive experience in epidemiology and real-world evidence
-
Minimum 5 years of Pharma or Biotech industry experience
-
Strong expertise in:
-
Phase IV / post-approval epidemiologic study design
-
Retrospective real-world data (RWD) analyses
-
Observational research methodologies
-
Experience overseeing vendors/CROs and critically evaluating statistical methodologies
-
Proficiency with statistical software (R SAS Stata) and strong understanding of claims/EHR data structures
-
Demonstrated ability to work autonomously in a global matrixed environment
-
Flexibility to support EU collaboration across time zones
Preferred Qualifications
-
Experience supporting regulatory or HTA-facing RWE deliverables
-
Vaccines infectious disease or public health epidemiology background
-
Experience with systematic literature reviews and meta-analyses
-
R programming skills including simulations power calculations or Shiny applications
-
Experience with data extraction cleaning and standardization for RWD
-
Prior authorship of scientific publications and presentations
-
Experience supporting EU feasibility assessments and RWE expectations
Role Highlights
-
Senior-level RWE leadership without people management responsibilities
-
High-visibility Phase IV and real-world effectiveness portfolio
-
Global collaboration with strong EU engagement
-
Remote flexibility within the United States
Qualified candidates with deep RWE and epidemiology expertise strong methodological grounding and Phase IV experience in Pharma/Biotech are encouraged to apply.
Job Title: Associate Director Real World Evidence (RWE) Science Phase IV / Post-Approval (Contract) Location: United States (Remote; Eastern Time business hours preferred) Duration: 7-Month Contract (Full-Time 40 hours/week) Start: Targeting Early March 2026 We are seeking an experienced Associa...
Job Title: Associate Director Real World Evidence (RWE) Science Phase IV / Post-Approval (Contract)
Location: United States (Remote; Eastern Time business hours preferred)
Duration: 7-Month Contract (Full-Time 40 hours/week)
Start: Targeting Early March 2026
We are seeking an experienced Associate Director Real World Evidence (RWE) Science to provide coverage for a Phase IV / post-approval RWE portfolio within a global Medical Affairs environment. This is a senior-level individual contributor role requiring deep epidemiology and real-world evidence expertise strong methodological leadership and the ability to independently manage ongoing studies with minimal ramp-up.
This position supports global stakeholders including Europe and requires flexibility for early morning meetings aligned to EU collaboration.
Key Responsibilities
-
Lead scientific oversight of Phase IV and post-approval real-world evidence (RWE) and observational studies
-
Provide methodological and technical leadership for study design feasibility assessments and evidence planning (EU focus)
-
Oversee vendors/CROs conducting outsourced analyses; review protocols statistical analysis plans and outputs to ensure scientific rigor
-
Conduct and/or supervise systematic literature reviews (SLRs) and meta-analyses
-
Contribute to development of RWE plans aligned with regulatory HTA and post-approval commitments
-
Support retrospective analyses leveraging real-world data sources (claims EHR registries)
-
Guide protocol development for observational studies and pragmatic trials
-
Perform evidence reviews to inform regulatory submissions reimbursement strategy and medical strategy
-
Collaborate with Regional Medical Affairs on scientific exchange and external RWE engagement
-
Support development of abstracts posters manuscripts and internal scientific communications
Required Qualifications
-
Advanced degree (MD PhD or MS) in Epidemiology Biostatistics Public Health or related field
-
8 10 years of progressive experience in epidemiology and real-world evidence
-
Minimum 5 years of Pharma or Biotech industry experience
-
Strong expertise in:
-
Phase IV / post-approval epidemiologic study design
-
Retrospective real-world data (RWD) analyses
-
Observational research methodologies
-
Experience overseeing vendors/CROs and critically evaluating statistical methodologies
-
Proficiency with statistical software (R SAS Stata) and strong understanding of claims/EHR data structures
-
Demonstrated ability to work autonomously in a global matrixed environment
-
Flexibility to support EU collaboration across time zones
Preferred Qualifications
-
Experience supporting regulatory or HTA-facing RWE deliverables
-
Vaccines infectious disease or public health epidemiology background
-
Experience with systematic literature reviews and meta-analyses
-
R programming skills including simulations power calculations or Shiny applications
-
Experience with data extraction cleaning and standardization for RWD
-
Prior authorship of scientific publications and presentations
-
Experience supporting EU feasibility assessments and RWE expectations
Role Highlights
-
Senior-level RWE leadership without people management responsibilities
-
High-visibility Phase IV and real-world effectiveness portfolio
-
Global collaboration with strong EU engagement
-
Remote flexibility within the United States
Qualified candidates with deep RWE and epidemiology expertise strong methodological grounding and Phase IV experience in Pharma/Biotech are encouraged to apply.
View more
View less